These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17061220)

  • 1. Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.
    Mauget-Faÿsse M; Quaranta-El Maftouhi M; De La Marnièrre E; Leys A
    Eur J Ophthalmol; 2006; 16(5):695-704. PubMed ID: 17061220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
    Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
    Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
    Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
    Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
    Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Tano Y
    Br J Ophthalmol; 2008 Jul; 92(7):936-40. PubMed ID: 18577645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
    Quaranta M; Mauget-Faÿsse M; Coscas G
    Am J Ophthalmol; 2002 Aug; 134(2):277-80. PubMed ID: 12140043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Matsumiya W; Honda S; Otsuka K; Miki A; Nagai T; Imai H; Kusuhara S; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):541-548. PubMed ID: 27687988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
    Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
    Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Maruko I; Iida T; Sugano Y; Saito M; Sekiryu T
    Am J Ophthalmol; 2011 Apr; 151(4):594-603.e1. PubMed ID: 21295766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.
    Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P
    BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.
    Koh A; Lai TYY; Takahashi K; Wong TY; Chen LJ; Ruamviboonsuk P; Tan CS; Feller C; Margaron P; Lim TH; Lee WK;
    JAMA Ophthalmol; 2017 Nov; 135(11):1206-1213. PubMed ID: 28983556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy: long-term results].
    Saito M; Nagayama D; Iida T
    Nippon Ganka Gakkai Zasshi; 2009 Aug; 113(8):792-9. PubMed ID: 19715154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
    Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
    Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
    Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Otani A; Nakayama Y; Yoshimura N
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.